Buscar resultados de ensayos clínicos
Endometrial Neoplasms - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Follow-up Care After Treatment for Endometrial Cancer Condición: Endometrial Neoplasm Fecha: 2008-09-09 |
Recruiting |
Nombre del estudio: The Role of Indocyanine Green to Identify Sentinel Lymph Node in Uterine Cancer Condición: Endometrial Neoplasm Fecha: 2016-06-24 Intervenciones: Procedure: Sentinel lymph node mapping Before laparoscopic hysterectomy and lymphadenectomy procedure fo |
Withdrawn |
Nombre del estudio: Lenvatinib in Second Line Endometrial Carcinoma Condición: Endometrial Neoplasms Fecha: 2016-08-18 Intervenciones:
|
Recruiting |
Nombre del estudio: Phase 2 Study of MLN0128, Combination of MLN0128 With MLN1117, Paclitaxel and Combination of MLN0128 With Paclitaxel in Women With Endometrial Cancer Condición: Endometrial Neoplasms Fecha: 2016-03-28 Intervenciones:
|
Completed |
Nombre del estudio: Studies of the Tumour Suppressor Gene PTEN - Endometrial Cancer Condición: Endometrial Neoplasms Fecha: 2011-02-11 Intervenciones:
|
Recruiting |
Nombre del estudio: Sentinel Lymph Node Detection in Endometrial Cancer Condición: Endometrial Neoplasms Fecha: 2015-11-05 Intervenciones: Procedure: Sentinel node procedure Patients with Endometrial cancer undergo Sentinel node procedure usin |
Recruiting |
Nombre del estudio: Indocyanine Green Versus Blue Dye for Detection of Sentinel Lymph Node In Endometrial Cancer Condición: Endometrial Neoplasms Fecha: 2015-09-29 Intervenciones: Procedure: Sentinel lymph node biopsy |
Active, not recruiting |
Nombre del estudio: The Feasibility Study of the Li Brush for the Screening of Endometrial Cancer in the Postmenopausal Period Condición: Endometrial Neoplasms Fecha: 2015-07-08 |
Completed |
Nombre del estudio: Diet and Physical Activity in Uterine Cancer Survivors Condición: Endometrial Neoplasms Fecha: 2015-04-20 Intervenciones: Behavioral: Shape-Up following cancer treatment The programme is based on "Social Cognitive Theory& |
Withdrawn |
Nombre del estudio: Ponatinib in the Treatment of FGFR Mutation Positive Recurrent or Persistent Endometrial Carcinoma Condición: Endometrial Neoplasms Fecha: 2013-06-25 Intervenciones: Drug: Ponatinib Ponatinib 45 mg daily for 4 weeks (4 weeks equal one cycle) |